Skip to main content
OpenTrials

Clinical trial condition

Uterine Cervical Diseases

Explore clinical trials studying Uterine Cervical Diseases. Study availability and eligibility vary by location and protocol.

1,753 public trials 368 recruiting studies
Refine in advanced search Browse all conditions

Uterine Cervical Diseases trial results

Active, Not Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

NCT05438420

Conditions
Cervical Cancer, Digestive System Diseases, Digestive System Neoplasms, +25 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • CHA Bundang Medical Center Seongnam-si, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details
Active, Not Recruiting

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

NCT05081609

Conditions
2L+ Cervical Cancer, Advanced Solid Tumor, Female Urogenital Diseases, +27 more
Locations
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Los Angeles, California, United States
  • Ascendis Pharma Investigational Site Springfield, Illinois, United States
  • Ascendis Pharma Investigational Site Louisville, Kentucky, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss

NCT04065269

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +26 more
Locations
  • The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • University of Montreal Hospital Centre Montreal, Quebec, Canada
  • Royal United Hospital Bath, United Kingdom
View Trial Details
Active, Not Recruiting

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

NCT05527184

Conditions
Adnexal Diseases, Cervical Cancer, Disease Attributes, +23 more
Locations
  • University of Alabama at Birmingham /ID# 269045 Birmingham, Alabama, United States
  • City of Hope National Medical Center /ID# 269036 Duarte, California, United States
  • Moores Cancer Center /ID# 269040 La Jolla, California, United States
  • University of California Los Angeles Medical Center /ID# 269037 Los Angeles, California, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068

Conditions
Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Oklahoma City, Oklahoma, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer

NCT04068753

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations
  • Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Louisiana State University Health Science Center New Orleans, Louisiana, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • University of Virginia Cancer Center Charlottesville, Virginia, United States
View Trial Details

Related conditions